Inovin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-07-2024
- Paid Up Capital ₹ 0.10 M
as on 11-07-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
About Inovin Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manav Garg and Rishabh Garg serve as directors at the Company.
- CIN/LLPIN
U74999CH2018PTC042017
- Company No.
042017
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Inovin Pharmaceuticals Private Limited offer?
Inovin Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Common Disease Medicines, Anti-Itch Skin Cream, Digestive System Drugs & Medicines, Anti Ulcer Drugs, Anti Infective Drugs & Medicines, Antibacterial Drugs, Multivitamin Syrup & Drops, Antifungal Cream, Ointment & Powder.
Who are the key members and board of directors at Inovin Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manav Garg  | Director | 02-Jan-2023 | Current |
| Rishabh Garg | Additional Director | 13-Jan-2020 | Current |
Financial Performance and Corporate Structure Insights of Inovin Pharmaceuticals.
Enhance accessibility to Inovin Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Inovin Pharmaceuticals?
Unlock access to Inovin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
3 years 6 months Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Inovin Pharmaceuticals?
Unlock and access historical data on people associated with Inovin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inovin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inovin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
